No Data
10-Q: Q3 2024 Earnings Report
Express News | Denali Capital Acquisition Corp: Co. Not in Compliance With Nasdaq Listing Rule 5450(B)(2)(a)
Denali Capital Acquisition Deposits $15K Into Trust Account To Fund Extension Until October 11, 2024; Funded Via Convertible Promissory Note With Scilex Holding Company For Up To $180K, Convertible Into Class A Shares At $10 Per Share
Express News | Denali Capital Acquisition: Combined Co to Be Renamed Semnur Pharmaceuticals, Inc., Common Stock to Be Listed on Nasdaq Under Ticker Symbols "Smnr"
Express News | Denali Capital Acquisition: Scilex Expected to Be Majority Holder of Combined Co Following Completion of Deal
Express News | Denali Capital Acquisition Corp: Pre-Transaction Equity Value of Semnur at $2.5 Bln
No Data
No Data